EE348 The Cost-Effectiveness of Belimumab for the Treatment of Patients With Systemic Lupus Erythematosus (SLE) in China
Dec 1, 2022, 00:00 AM
10.1016/j.jval.2022.09.594
https://www.valueinhealthjournal.com/article/S1098-3015(22)02798-X/fulltext
Section Title :
Section Order :
10129
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)02798-X&doi=10.1016/j.jval.2022.09.594